Nanomedicine, 1743-5889

Journal

View graph of relations

Related Publications
  1. Limits and challenges in using transport inhibitors to characterize how nano-sized drug carriers enter cells

    Francia, V., Reker-Smit, C., Boel, G. & Salvati, A., 1-Jun-2019, In : Nanomedicine. 14, 12, p. 1533-1549 17 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Crucial role of the protein corona for the specific targeting of nanoparticles

    Mahmoudi, M., Sheibani, S., Milani, A. S., Rezaee, F., Gauberti, M., Dinarvand, R. & Vali, H., 2015, In : Nanomedicine. 10, 2, p. 215-226 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Next-generation nanoantibacterial tools developed from peptides

    de Vries, R., Andrade, C. A. S., Bakuzis, A. F., Mandal, S. M. & Franco, O. L., 2015, In : Nanomedicine. 10, 10, p. 1643-1661 19 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy

    Elsaesser, A., Barnes, C. A., McKerr, G., Salvati, A., Lynch, I., Dawson, K. A. & Howard, C. V., Sep-2011, In : Nanomedicine. 6, 7, p. 1189-1198 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Taxol (R)-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor (R) EL

    Vader, P., Fens, M. H. A. M., Sachini, N., van Oirschot, B. A., Andringa, G., Egberts, A. C. G., Gaillard, C. A. J. M., Rasmussen, J. T., van Wijk, R., van Solinge, W. W. & Schiffelers, R. M., Jul-2013, In : Nanomedicine. 8, 7, p. 1127-1135 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (6) »

ID: 5569332